Private Wealth Partners’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-9,586
Closed -$231K 116
2016
Q4
$231K Sell
9,586
-5,045
-34% -$140K 0.05% 101
2016
Q3
$406K Sell
14,631
-1,009
-6% -$26.7K 0.1% 90
2016
Q2
$381K Sell
15,640
-504
-3% -$14.3K 0.09% 97
2016
Q1
$542K Sell
16,144
-29,412
-65% -$926K 0.13% 90
2015
Q4
$1.36M Buy
45,556
+6,911
+18% +$233K 0.32% 64
2015
Q3
$1.22M Buy
38,645
+31,077
+411% +$1.52M 0.31% 63
2015
Q2
$366K Sell
7,568
-279
-4% -$11.8K 0.08% 111
2015
Q1
$340K Sell
7,847
-7,953
-50% -$286K 0.08% 121
2014
Q4
$416K Buy
+15,800
New +$346K 0.1% 115

Other funds holding PGEN

Private Wealth Partners's PGEN Position: Q1 2017 in Review

Private Wealth Partners sold out of Precigen (PGEN) in Q1 2017, closing a stake of 9,586 shares — an estimated $231K sold.

Private Wealth Partners first reported a position in PGEN in Q4 2014 and held it in 9 quarters. The position peaked at $1.36M in Q4 2015. 154 funds tracked by Wall St. Rank hold PGEN as of Q1 2017.

  • Private Wealth Partners reported no remaining Precigen position as of Q1 2017 after selling out during the quarter.
  • Private Wealth Partners sold 9,586 Precigen shares in Q1 2017, an estimated $231K.
  • Private Wealth Partners first reported a position in Precigen in Q4 2014 and held it in 9 quarters.
  • Private Wealth Partners's Precigen position peaked at $1.36M in Q4 2015.
  • 154 funds tracked by Wall St. Rank held Precigen as of Q1 2017.

Based on Private Wealth Partners's 13F filing for Q1 2017, filed 19 Apr 2017.